Results 81 to 90 of about 20,261,406 (206)
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. [PDF]
, 2017 Long-term functional outcomes of sofosbuvir-based antiviral treatment were evaluated in a cohort study involving 16 Italian centres within the international compassionate use programme for post-transplant hepatitis C virus (HCV) recurrence. Seventy-three
Burra, Patrizia +2 more
core +1 more source
Cellular and Molecular Gastroenterology and Hepatology, 2017 Background & Aims: Hepatitis C virus (HCV) is a leading cause of chronic liver diseases and the most common indication for liver transplantation in the United States.
Ursula Andreo +10 more
doaj
The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature [PDF]
, 2019 The second-generation of direct-acting antiviral agents are the current treatment for chronic viral hepatitis C infection. To evaluate the regression of liver fibrosis in patients receiving this therapy, liver biopsy remains the most accurate method, but
Alexescu, Teodora G +12 more
core +1 more source
VirusesDespite the availability of a vaccine against hepatitis B virus (HBV), this infection still causes public health problems, particularly in susceptible populations.
Carolina Silva +3 more
doaj +1 more source
Hepatitis C Screening in the Baby Boomer Cohort [PDF]
, 2017 The USPSTF recommends a one-time screening for Hepatitis C, irrespective of prior risk factors, for individuals born between 1945-1965. Many patients in this group may not be aware of this recommendation or understand very much about Hepatitis C ...
Hyson, Peter
core +1 more source
NATURAL HISTORY OF HEPATITIS C
, 2018 Hepatitis C infection is a common cause of cirrhosis and indication for liver transplantation in the United States. The incidence of chronic hepatitis C has been declining but rates of cirrhosis and hepatocellular carcinoma are projected to rise.
S. Lingala
semanticscholar +1 more source
Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis [PDF]
, 2018 Chronic coinfection with hepatitis C virus (HCV) and hepatitis B virus (HBV) is associated with adverse liver outcomes. The clinical impact of previous HBV infection on liver disease in HCV infection is unknown. We aimed at determining any association of
Allen, S. +20 more
core +4 more sources
Hepatitis C-vírus-fertőzés kiújulása májátültetés után. Mi változott az elmúlt 10 évben? [PDF]
, 2014 Introduction: Management of hepatitis C virus recurrence is a challenge after liver transplantation. Aim: The aim of the authors was to analyse the outcome of liver transplantation performed in hepatitis C virus positive patients during the past ten ...
Doros, Attila +19 more
core +1 more source
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
Clinical Infectious Diseases, 2016 In the United States, hepatitis C virus (HCV)-associated mortality is increasing. From 2003-2013, the number of deaths associated with HCV has now surpassed 60 other nationally notifiable infectious conditions combined.
Kathleen N Ly +3 more
semanticscholar +1 more source
Brazilian Journal of Infectious Diseases, 2015 Response-guided therapy is of limited use in developing countries because hepatitis C virus RNA detection by sensitive molecular methods is time- and labor-consuming and expensive.
Bo Feng +8 more
doaj